Discovery is major step forward in increased availability of organs and tissues for transplantation
A research team, led by the University of Minnesota, has discovered a groundbreaking process to successfully rewarm large-scale animal heart valves and blood vessels preserved at very low temperatures. The discovery is a major step forward in saving millions of human lives by increasing the availability of organs and tissues for transplantation through the establishment of tissue and organ banks.
The research was published today in Science Translational Medicine, a peer-reviewed research journal published by the American Association for the Advancement of Sciences (AAAS). The University of Minnesota holds two patents related to this discovery.
“This is the first time that anyone has been able to scale up to a larger biological system and demonstrate successful, fast, and uniform warming hundreds of degrees Celsius per minute of preserved tissue without damaging the tissue,” said University of Minnesota mechanical engineering and biomedical engineering professor John Bischof, the senior author of the study.
Bischof said in the past, researchers were only able to show success at about 1 milliliter of tissue and solution. This study scales up to 50 milliliters, which means there is a strong possibility they could scale up to even larger systems, like organs.
Currently, more than 60 percent of the hearts and lungs donated for transplantation must be discarded each year because these tissues cannot be kept on ice for longer than four hours. According to recent estimates, if only half of unused organs were successfully transplanted, transplant waiting lists could be eliminated within two years.
Long-term preservation methods, like vitrification, that cool biological samples to an ice-free glassy state using very low temperatures between -160 and -196 degrees Celsius have been around for decades. However, the biggest problem has been with the rewarming. Tissues often suffer major damage during the rewarming process making them unusable, especially at larger scales.
In this new study, the researchers addressed this rewarming problem by developing a revolutionary new method using silica-coated iron oxide nanoparticles dispersed throughout a cryoprotectant solution that included the tissue. The iron oxide nanoparticles act as tiny heaters around the tissue when they are activated using noninvasive electromagnetic waves to rapidly and uniformly warm tissue at rates of 100 to 200 degrees Celsius per minute, 10 to 100 times faster than previous methods.
After rewarming and testing for viability, the results showed that none of the tissues displayed signs of harm, unlike control samples rewarmed slowly over ice or those using convection warming. The researchers were also able to successfully wash away the iron oxide nanoparticles from the sample following the warming.
Bischof said the discovery is the result of his team’s research in many different fields to preserve or destroy cells and tissue at either ultra high temperatures or ultra low temperatures.
“We’ve gone to the limits of what we can do at very high temperatures and very low temperatures in these different areas,” Bischof said. “Usually when you go to the limits, you end up finding out something new and interesting. These results are very exciting and could have a huge societal benefit if we could someday bank organs for transplant.”
Although scaling up the system to accommodate entire organs will require further optimization, the authors are optimistic. They plan to start with rodent organs (such as rat and rabbit) and then scale up to pig organs and then, hopefully, human organs. The technology might also be applied beyond cryogenics, including delivering lethal pulses of heat to cancer cells.
Receive an email update when we add a new CRYOGENICS article.
The Latest on: Cryogenics
via Google News
The Latest on: Cryogenics
- Global Cryogenic Tanks Market 2020 Business Strategies – VRV S.p.A, Cryogas Equipment Private Ltd., Eden Cryogenics LLCon November 12, 2020 at 11:01 pm
The market report titled “Cryogenic Tanks Market - by Application (Transportation (Comprise Distribution) and Storage), by Product Type (Nitrogen, LNG, Argon, and Oxygen), and by Region: Global ...
- German cryogenics firm develops Covid-19 vaccine container solutionon November 10, 2020 at 12:53 am
Shipping and financial markets have reacted positively to yesterday’s hopeful Pfizer coronavirus vaccine news. However, logistical concerns continue to be raised about the distribution of the drug, ...
- Global Cryogenics pump Market Size By End User, By Region 2020 | Overview, Growth, Economics, Demand And Forecast Research Report To 2026on November 5, 2020 at 4:07 pm
Nov 06, 2020 (The Expresswire) -- The Cryogenics pump market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth ...
- Home with links to cryogenics, zoo and the 'Mayor of Onehunga' for saleon November 2, 2020 at 8:32 pm
It's only a short jaunt from the city today, but when the house at 2 Konini Rd, Hataitai was built, it was a horse-drawn buggy ride over Mt Victoria from Wellington. In the early 1900s, the ...
- Milton Street makes two acquisitionson November 2, 2020 at 12:23 pm
Milton Street Capital has acquired the life science businesses of Worthington Industries and International Cryogenics Inc. No financial terms were disclosed. At the closing, the two cryogenic ...
- Milton Street Capital forms IC Biomedical, acquiring the Life Sciences business of Worthington Industries and International Cryogenics, Inc.on November 2, 2020 at 3:10 am
International Cryogenics, Inc. ("ICI"), based in Indianapolis, IN, is a manufacturer of cryogenic aluminum, freezers, dewars, shippers and custom products for biomedical applications. With a long ...
- Milton Street Capital forms IC Biomedical, acquiring the Life Sciences business of Worthington Industries and International Cryogenics, Inc.on November 1, 2020 at 4:00 pm
HOUSTON , Nov. 2, 2020 /PRNewswire/ -- Milton Street Capital, a Houston -based lower middle market private equity firm, announced the simultaneous acquisition of the Life Sciences business of ...
- Vacuum and cryogenicson July 26, 2020 at 5:19 pm
The experiment was carried out inside a vacuum chamber filled with a low density nitrogen or argon gas. A wave plate – in the form of a small circular piece of material – was inserted into ...
- Thales Cryogenics B.V.on July 29, 2019 at 10:53 pm
Thales Cryogenics is the European leader in cryogenics and reserve lithium batteries. With two plants in Europe, more than 120 engineers and support staff, Thales Cryogenics has produced more than ...
via Bing News